Cytoreductive nephrectomy (CN) in patients with metastatic renal cell carcinoma (mRCC) has become underutilized since targeted therapy drugs have come on the market, and that may be contributing to ...

Impact of deferred cytoreductive nephrectomy in the era of the immunotherapy in metastatic renal cell carcinoma: A multicenter retrospective study. This is an ASCO Meeting Abstract from the 2025 ASCO ...

A Canadian study recently assessed 709 patients with intermediate- and high-risk synchronous mRCC with or without sarcomatoid features. Most patients had clear cell histology and were treated with ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. There's a multicentered trial called ...